Brief: Gain Therapeutics Inc Reports Third Quarter 2021 Financial Results And Business Update
Nov 12 (Reuters) - Gain Therapeutics Inc GANX.O :
* GAIN THERAPEUTICS, INC. REPORTS THIRD QUARTER 2021
FINANCIAL
RESULTS AND BUSINESS UPDATE
* Q3 GAAP LOSS PER SHARE $0.39
* $40.98 MILLION IN CASH AS OF SEPTEMBER 30, 2021, PROVIDES
RUNWAY
INTO SECOND HALF OF 2023
Source text for Eikon: ID:nGNX2rSgMh
Further company coverage: GANX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gain Therapeutics
See all newsU.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Gain Therapeutics climbs on narrower-than-expected quarterly loss
Gain Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall